Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, was named the recipient of the first-ever License of the Year award presented from the University of Pittsburgh Innovation Institute (“UPII”). The award honors advances made with GNPX’s license from University of Pittsburgh toward progressing the development…
Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has completed a series of studies evaluating the safety and anti-inflammatory, anti-aging, and antimicrobial properties of its cannabigerol (“CBG”) when used on skin. The studies were conducted in collaboration with Signum Biosciences Inc.,…
Knightscope CEO William Santana Li is a featured guest on an upcoming episode of the Dealmaker Show, hosted by Oren Klaff. During the interview, Santana explains how the company’s autonomous security robots (“ASRs”) work, who target customers are and how the robots work with humans and surveillance software to enhance public safety and security. The…
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has appointed two new positions at XP Diagnostics GmbH, its wholly owned German subsidiary. Wolfgang Probst will serve as the company’s new chief operations officer and Manfred Buchberger will be the new head…
180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, has announced collection of all patient data for its phase 2b Dupuytren’s disease trial, which was sponsored by the University of Oxford. The double-blind placebo-controlled trial involved 181 patients…
Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a provider of virtual and augmented reality (“AR”) experience technologies and services, today announced plans to host its virtual 2021 Investor Day. The event is scheduled to take place from 1:00pm-3:00 p.m. ET on Thursday, April 29, 2021. As detailed in the update, members of the…
Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be presenting at the upcoming Planet MicroCap Showcase. Scheduled to take place on April 20–22, 2021, the virtual Planet MicroCap event will feature 66 small-cap,…
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its software-as-a-service (“SaaS”) platform, Sequire, today announced that Steve DeAngelo, Dr. Sue Sisley, Emily Paxhia, Steven Hawkins, and Dr. Jeffrey Chen will all be participating as keynote speakers at the first-ever Sequire Cannabis Conference. The one-day virtual event…
Knightscope, an advanced security technology company that builds fully autonomous security robots (“ASRs”) that deter, detect and report, has announced that more than 1,000 investors have climbed aboard in just the last few days. The announcement noted that these investors will allow the company to add new American jobs, build and sell more ASR devices,…
Brain Scientific (OTCQB: BRSF),a neurology-focused medical device and software company, has released its 2020 financial results and has filed its annual report for the fiscal year ended Dec. 31, 2020. Company highlights include bringing the production of NeuroCaps(TM) to the United States; launching the commercial roll-out of its NeuroEEG(TM) and NeuroCap(TM) on a limited basis…
Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced the formation of its clinical advisory board. Additions to the board include Maurizio Fava, MD, psychiatrist-in-chief in the Department of Psychiatry at Massachusetts General Hospital, Lynn Marie Morski, MD, Esq., president of the Psychedelic Medicine Association, and Anthony Back, MD,…
AmpliTech Group (NASDAQ: AMPG, AMPGW), a designer, developer and manufacturer of custom and standard state-of-the-art RF (“RF”) components for commercial, SATCOM, 5G, quantum computing, space, defense and military markets, has closed on its registered direct offering. The offering comprised 2,715,000 shares of common stock priced at-the-market under Nasdaq rules. In addition to its common stock,…
HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, recently reassured investors that the company is moving forward and that all aspects of the company are sound. HempFusion made the announcement in response to recent trading activity that saw its share prices…
Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has submitted an application to list its common shares on the NASDAQ Capital Market. The strategic move is designed to provide further opportunities to attract institutional and retail investors, thereby allowing the company to increase its investor base both in the United States…
TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has received a $1 million warehouse order for its TAAT(TM) Original, Smooth and Menthol nicotine-free, tobacco-free cigarette alternative. The order was placed by Worldwide Vape Distribution (“WWV”), a distribution company with access to more than 10,000 retail stores across 38 states. The order will be…
Predictive Oncology (NASDAQ: POAI), through its Skyline Medical division, is positioned for opportunity in the fluid management systems and accessories market, which is projected to reach $16.1 billion in 2025 from $8.5 billion in 2020, expanding at a CAGR of 13.6%. These figures are according MarketsandMarkets, which cites several growth factors including technological advancements in…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company whose lead drug candidate Berubicin has yielded promising results in the treatment of glioblastoma multiforme (“GBM”), has made equally significant strides with its second drug candidate, WP1244. Still currently in development, preclinical work for WP1244 is expected to continue during 2021 and 2022. “WP1244 is a DNA-binding agent…
Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, was featured in a research report by H.C. Wainwright & Co. The piece covers ongoing wellfield development and resource delineation drilling at UEC’s Burke Hollow in-situ recovery (“ISR”) uranium project in Texas, as well as its fully funded physical uranium initiative.…
Kaival Brands (OTCQB: KAVL) today announced that Bidi Vapor LLC has successfully completed the regulatory process to enter seven additional international markets. This brings the total of new international countries open for distribution to 11, including Australia, Austria, the Czech Republic, France, Germany, Italy, the Netherlands, New Zealand, Russia, Spain, and the United Kingdom. Kaival…
Ideanomics (NASDAQ: IDEX), a global company focused on the convergence of financial services and industries experiencing technological disruption, has announced plans to release its Q1 2021 financial report on Monday, May 17, 2021. The news release noted that during the first quarter of this year, IDEX has transformed its business through acquisitions transacted through both Ideanomics…